ArticleBMJ (Clinical research ed.)2017
Do cancer drugs improve survival or quality of life?
Article in BMJ (Clinical research ed.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review.JAMA network open · 2021Pooled it
- Synthesis, characterization, anti-proliferative, and apoptotic activity of a novel quinazoline-containing 1,2,3-triazole toward three human cancer cells.Scientific reports · 2025Article
- Reporting quality of dose-expansion cohorts in trials of anticancer drugs could be improved: a cross-sectional study.Trials · 2025Article
- The therapeutic futility paradox: insights from oncological drug litigation in Ecuador.Frontiers in medicine · 2025Article
- Clinical trials and tribulations.EMBO reports · 2024Review
- Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2023Review
- Opportunities for Savings in Risk Arrangements for Oncologic Care.JAMA health forum · 2023Observational
- Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient Benefits?Clinical drug investigation · 2023Review
- Should personalised dosing have a role in cancer treatment?Frontiers in oncology · 2023Article
- Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer drugs.ESMO open · 2022Article
- Multiple deadlocks in the development of nonprofit drugs.Drug discovery today · 2022Article
- Monitoring and modulation of the tumor microenvironment for enhanced cancer modeling.Experimental biology and medicine (Maywood, N.J.) · 2022Review
- Dissecting the Mechanism of Action of Spiperone-A Candidate for Drug Repurposing for Colorectal Cancer.Cancers · 2022Article
- Bias against Vitamin C in Mainstream Medicine: Examples from Trials of Vitamin C for Infections.Life (Basel, Switzerland) · 2022Review
- Molecular Targets of Natural Compounds with Anti-Cancer Properties.International journal of molecular sciences · 2021Review
- An urgent call to raise the bar in oncology.British journal of cancer · 2021Review
- The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?Cancer management and research · 2021Article
- Article
- Towards a cancer mission in Horizon Europe: recommendations.Molecular oncology · 2020Article
- MET ectodomain shedding is associated with poor disease-free survival of patients diagnosed with oral squamous cell carcinoma.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.